Skip to main content
logo
Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
150.27
-0.06 (-0.04%)
At close: Aug 15, 2025, 4:00 PM
147.27
-3.00 (-2.00%)
After-hours: Aug 15, 2025, 7:11 PM EDT

Krystal Biotech Revenue

Krystal Biotech had revenue of $96.04M in the quarter ending June 30, 2025, with 36.65% growth. This brings the company's revenue in the last twelve months to $359.21M, up 116.08% year-over-year. In the year 2024, Krystal Biotech had annual revenue of $290.52M with 473.02% growth.

Revenue (ttm)
$359.21M
Revenue Growth
+116.08%
P/S Ratio
12.05
Revenue / Employee
$1,306,200
Employees
275
Market Cap
4.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024290.52M239.82M473.02%
Dec 31, 202350.70M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

KRYS News

More News